The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain

Neurochemistry International

Volumn 50, Issue 6, 2007, Pages 848-857

  Li, Qi ^a   Lu, Gang ^b   Antonio, G E ^a   Mak, Y T ^a   Rudd, John A ^a   Fan, Ming ^c   Yew, David T ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Magnetic resonance imaging (MRI); Morris water maze; Open field test (OF test); Prepulse inhibition; Real time PCR; Spontaneously hypertensive rat (SHR); Water finding

Indexed keywords

CATECHOLAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; TYROSINE 3 MONOOXYGENASE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; CATECHOLAMINE SYNTHESIS; CAUDATE NUCLEUS; CEREBELLUM VERMIS; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; GENE EXPRESSION; JUVENILE; LEARNING; LOCOMOTION; MALE; MEMORY; MESENCEPHALON; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN FIELD TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PUTAMEN; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPATIAL MEMORY; SPONTANEOUSLY HYPERTENSIVE RAT; TEMPORAL CORTEX; WISTAR KYOTO RAT;

ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN CHEMISTRY; CUES; DOPAMINE; FEMALE; GENE EXPRESSION REGULATION; LEARNING; MAGNETIC RESONANCE IMAGING; MALE; MAZE LEARNING; MEMORY; MOTOR ACTIVITY; RATS; RATS, INBRED SHR; RATS, INBRED WKY; STARTLE REACTION;

ANIMALIA; RATTUS;

EID: 34248211046     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.02.005     Document Type: Article

References (65)

1. Anisman H., and McIntyre D.C. Conceptual, spatial, and cue learning in the Morris water maze in fast or slow kindling rats: attention-deficit comorbidity. J. Neurosci. 22 (2002) 7809-7817
2. Avale M.E., Falzone T.L., Gelman D.M., Low M.J., Grandy D.K., and Rubinstein M. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention-deficit/hyperactivity disorder. Mol. Psychiatry 9 (2004) 718-726
3. Barkley R.A., and Biederman J. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 36 (1997) 1204-1210
4. Barnett R., Maruff P., Vance A., Luk E.S., Costin J., Wood C., and Pantelis C. Abnormal executive function in attention-deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory. Psychol. Med. 31 (2001) 1107-1115
5. Berger D.F., and Sagvolden T. Sex differences in operant discrimination behaviour in an animal model of attention-deficit hyperactivity disorder. Behav. Brain Res. 94 (1998) 73-82
6. Boix F., Qiao S.W., Kolpus T., and Sagvolden T. Chronic l-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of attention-deficit/hyperactivity disorder. Behav. Brain Res. 94 (1998) 153-162
7. Brown R.T., Freeman W.S., Perrin J.M., Stein M.T., Amler R.W., Feldman H.M., Pierce K., and Wolraich M.L. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 107 (2001) E43
8. Castanon N., Hendley E.D., Fan X.M., and Mormede P. Psychoneuroendocrine profile associated with hypertension or hyperactivity in spontaneously hypertensive rats. Am. J. Physiol. 265 (1993) R1304-R1310
9. Castellanos F.X., Giedd J.N., Marsh W.L., Hamburger S.D., Vaituzis A.C., Dickstein D.P., Sarfatti S.E., Vauss Y.C., Snell J.W., Lange N., Kaysen D., Krain A.L., Ritchie G.F., Rajapakse J.C., and Rapoport J.L. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry 53 (1996) 607-616
10. Chambers C.D., Bellgrove M.A., Stokes M.G., Henderson T.R., Garavan H., Robertson I.H., Morris A.P., and Mattingley J.B. Executive "brake failure" following deactivation of human frontal lobe. J. Cogn. Neurosci. 18 (2006) 444-455
11. de Villiers A.S., Russell V.A., Sagvolden T., Searson A., Jaffer A., and Taljaard J.J. Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder. Neurochem. Res. 20 (1995) 427-433
12. Dimitrov M., Nakic M., Elpern-Waxman J., Granetz J., O'Grady J., Phipps M., Milne E., Logan G.D., Hasher L., and Grafman J. Inhibitory attentional control in patients with frontal lobe damage. Brain Cogn. 52 (2003) 258-270
13. Drolet G., Proulx K., Pearson D., Rochford J., and Deschepper C.F. Comparisons of behavioral and neurochemical characteristics between WKY, WKHA, and Wistar rat strains. Neuropsychopharmacology 27 (2002) 400-409
14. Durston S., Hulshoff Pol H.E., Schnack H.G., Buitelaar J.K., Steenhuis M.P., Minderaa R.B., Kahn R.S., and van Engeland H. Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. J. Am. Acad. Child Adolesc. Psychiatry 43 (2004) 332-340
15. Durston S., Tottenham N.T., Thomas K.M., Davidson M.C., Eigsti I.M., Yang Y., Ulug A.M., and Casey B.J. Differential patterns of striatal activation in young children with and without ADHD. Biol. Psychiatry 53 (2003) 871-878
16. Eells J.B. The control of dopamine neuron development, function and survival: insights from transgenic mice and the relevance to human disease. Curr. Med. Chem. 10 (2003) 857-870
17. Faraone S.V., and Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol. Psychiatry 44 (1998) 951-958
18. Ferguson S.A., and Cada A.M. Spatial learning/memory and social and nonsocial behaviors in the spontaneously hypertensive Wistar-Kyoto and Sprague-Dawley rat strains. Pharmacol. Biochem. Behav. 77 (2004) 583-594
19. Ferguson S.A., Racey F.D., Paule M.G., and Holson R.R. Behavioral effects of methylazoxymethanol-induced micrencephaly. Behav. Neurosci. 107 (1993) 1067-1076
20. Filipek P.A., Semrud-Clikeman M., Steingard R.J., Renshaw P.F., Kennedy D.N., and Biederman J. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 48 (1997) 589-601
21. Glickstein S.B., and Schmauss C. Dopamine receptor functions: lessons from knockout mice [corrected]. Pharmacol. Ther. 91 (2001) 63-83
22. Goldman-Rakic P.S. Regional and cellular fractionation of working memory. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 13473-13480
23. Hendley E.D. WKHA rats with genetic hyperactivity and hyperreactivity to stress: a review. Neurosci. Biobehav. Rev. 24 (2000) 41-44
24. Hinshaw S.P. Academic underachievement, attention deficits, and aggression: comorbidity and implications for intervention. J. Consult Clin. Psychol. 60 (1992) 893-903
25. Hovatta I., Tennant R.S., Helton R., Marr R.A., Singer O., Redwine J.M., Ellison J.A., Schadt E.E., Verma I.M., Lockhart D.J., and Barlow C. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 438 (2005) 662-666
26. Ichihara K., Nabeshima T., and Kameyama T. Dopaminergic agonists impair latent learning in mice: possible modulation by noradrenergic function. J. Pharmacol. Exp. Ther. 264 (1993) 122-128
27. Jentsch J.D. Impaired visuospatial divided attention in the spontaneously hypertensive rat. Behav. Brain Res. 157 (2005) 323-330
28. Kataoka M., Kuwahara R., Matsuo R., Sekiguchi M., Inokuchi K., and Takahashi M. Development- and activity-dependent regulation of SNAP-25 phosphorylation in rat brain. Neurosci. Lett. 407 (2006) 258-262
29. Khubchandani M., Mallick H.N., Jagannathan N.R., and Mohan K.V. Stereotaxic assembly and procedures for simultaneous electrophysiological and MRI study of conscious rat. Magn. Reson. Med. 49 (2003) 962-967
30. Konrad K., Neufang S., Thiel C.M., Specht K., Hanisch C., Fan J., Herpertz-Dahlmann B., and Fink G.R. Development of attentional networks: an fMRI study with children and adults. Neuroimage 28 (2005) 429-439
31. Kustanovich V., Merriman B., McGough J., McCracken J.T., Smalley S.L., and Nelson S.F. Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. Mol. Psychiatry 8 (2003) 309-315
32. LaHoste G.J., Swanson J.M., Wigal S.B., Glabe C., Wigal T., King N., and Kennedy J.L. Dopamine D4 receptor gene polymorphism is associated with attention-deficit hyperactivity disorder. Mol. Psychiatry 1 (1996) 121-124
33. Leo D., Sorrentino E., Volpicelli F., Eyman M., Greco D., Viggiano D., di Porzio U., and Perrone-Capano C. Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD. Neurosci. Biobehav. Rev. 27 (2003) 661-669
34. Levant B. The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol. Rev. 49 (1997) 231-252
35. Li L., and Schafer J.A. Dopamine inhibits vasopressin-dependent cAMP production in the rat cortical collecting duct. Am. J. Physiol. 275 (1998) F62-F67
36. Linthorst A.C., van Giersbergen P.L., Gras M., Versteeg D.H., and de Jong W. The nigrostriatal dopamine system: role in the development of hypertension in spontaneously hypertensive rats. Brain Res. 639 (1994) 261-268
37. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
38. Missale C., Nash S.R., Robinson S.W., Jaber M., and Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 78 (1998) 189-225
39. Mostofsky S.H., Reiss A.L., Lockhart P., and Denckla M.B. Evaluation of cerebellar size in attention-deficit hyperactivity disorder. J. Child Neurol. 13 (1998) 434-439
40. Pang X., Lee B., Chui L., Preiksaitis J.K., and Monroe S.S. Evaluation and validation of real-time reverse transcription-pcr assay using the LightCycler system for detection and quantitation of norovirus. J. Clin. Microbiol. 42 (2004) 4679-4685
41. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
42. Pfaffl M.W., Horgan G.W., and Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30 (2002) e36
43. Powell S.B., Paulus M.P., Hartman D.S., Godel T., and Geyer M.A. RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice. Neuropharmacology 44 (2003) 473-481
44. Quinlivan M., Dempsey E., Ryan F., Arkins S., and Cullinane A. Real-time reverse transcription PCR for detection and quantitative analysis of equine influenza virus. J. Clin. Microbiol. 43 (2005) 5055-5057
45. Ralph R.J., Varty G.B., Kelly M.A., Wang Y.M., Caron M.G., Rubinstein M., Grandy D.K., Low M.J., and Geyer M.A. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J. Neurosci. 19 (1999) 4627-4633
46. Ross R.G., Harris J.G., Olincy A., and Radant A. Eye movement task measures inhibition and spatial working memory in adults with schizophrenia, ADHD, and a normal comparison group. Psychiatry Res. 95 (2000) 35-42
47. Rubinstein M., Phillips T.J., Bunzow J.R., Falzone T.L., Dziewczapolski G., Zhang G., Fang Y., Larson J.L., McDougall J.A., Chester J.A., Saez C., Pugsley T.A., Gershanik O., Low M.J., and Grandy D.K. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90 (1997) 991-1001
48. Russell V., de Villiers A., Sagvolden T., Lamm M., and Taljaard J. Differences between electrically-, ritalin- and d-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behav. Brain Res. 94 (1998) 163-171
49. Russell V.A., Sagvolden T., and Johansen E.B. Animal models of attention-deficit hyperactivity disorder. Behav. Brain Funct. 1 (2005) 9
50. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci. Biobehav. Rev. 24 (2000) 31-39
51. Sagvolden T., Hendley E.D., and Knardahl S. Behavior of hypertensive and hyperactive rat strains: hyperactivity is not unitarily determined. Physiol. Behav. 52 (1992) 49-57
52. Sagvolden T., Johansen E.B., Aase H., and Russell V.A. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav. Brain Sci. 28 (2005) 397-419
53. Sagvolden T., Russell V.A., Aase H., Johansen E.B., and Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol. Psychiatry 57 (2005) 1239-1247
54. Sang Y., Ortega M.T., Blecha F., Prakash O., and Melgarejo T. Molecular cloning and characterization of three beta-defensins from canine testes. Infect. Immun. 73 (2005) 2611-2620
55. Scahill L., and Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc. Psychiatr. Clin. N. Am. 9 (2000) 541-555, vii
56. Selak S., and Fritzler M.J. Altered neurological function in mice immunized with early endosome antigen 1 BMC. Neuroscience 5 (2004) 2
57. Silver L.B. Attention-deficit/hyperactivity disorder in adult life. Child Adolesc. Psychiatr. Clin. N. Am. 9 (2000) 511-523
58. Slopien A., Dmitrzak-Weglarz M., Rybakowski F., Rajewski A., and Hauser J. Genetic background of ADHD: genes of the serotonergic system, other candidate genes, endophenotype. Psychiatr. Pol. 40 (2006) 33-42
59. Sorensen J.B., Wiederhold K., Muller E.M., Milosevic I., Nagy G., de Groot B.L., Grubmuller H., and Fasshauer D. Sequential N- to C-terminal SNARE complex assembly drives priming and fusion of secretory vesicles. EMBO J. 25 (2006) 955-966
60. Swanson J.M., Sunohara G.A., Kennedy J.L., Regino R., Fineberg E., Wigal T., Lerner M., Williams L., LaHoste G.J., and Wigal S. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention-deficit hyperactivity disorder (ADHD): a family-based approach. Mol. Psychiatry 3 (1998) 38-41
61. Taylor E. Clinical foundations of hyperactivity research. Behav. Brain Res. 94 (1998) 11-24
62. Terry Jr. A.V., Hernandez C.M., Buccafusco J.J., and Gattu M. Deficits in spatial learning and nicotinic-acetylcholine receptors in older, spontaneously hypertensive rats. Neuroscience 101 (2000) 357-368
63. Vandesompele J., De P.K., Pattyn F., Poppe B., Van R.N., De P.A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) 0034 (Research)
64. Whitehorn D., Atwater D.G., Low W.C., Gellis J.E., and Hendley E.D. Independence of blood pressure and locomotor hyperactivity in normotensive and genetically hypertensive rat. Behav. Neural Biol. 37 (1983) 357-361
65. Wilens T.E., Biederman J., and Spencer T.J. Attention-deficit/hyperactivity disorder across the lifespan. Annu. Rev. Med. 53 (2002) 113-131